Authors' Reply.
作者信息
Clarke Candice L, Prendecki Maria, McAdoo Stephen P, Willicombe Michelle
机构信息
Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom
Imperial College Renal and Transplant Centre, Imperial College Healthcare National Health Service Trust, Hammersmith Hospital, London, United Kingdom.
出版信息
J Am Soc Nephrol. 2020 Dec;31(12):2967-2968. doi: 10.1681/ASN.2020091276. Epub 2020 Sep 29.
Abstract
摘要
相似文献
1
Authors' Reply.作者回复。
J Am Soc Nephrol. 2020 Dec;31(12):2967-2968. doi: 10.1681/ASN.2020091276. Epub 2020 Sep 29.
2
SARS-CoV-2 seroprevalence in Spain - Authors' reply.西班牙2019冠状病毒病血清流行率——作者回复
Lancet. 2020 Nov 7;396(10261):1484-1485. doi: 10.1016/S0140-6736(20)32266-2.
3
Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.采用血清学筛查检测血液透析患者中新冠病毒感染的患病率
J Am Soc Nephrol. 2020 Dec;31(12):2966-2967. doi: 10.1681/ASN.2020081193. Epub 2020 Sep 29.
4
High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.使用血清学筛查检测到血液透析患者中无症状 COVID-19 感染的高发生率。
J Am Soc Nephrol. 2020 Sep;31(9):1969-1975. doi: 10.1681/ASN.2020060827. Epub 2020 Jul 30.
5
Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply.严重急性呼吸综合征冠状病毒2型的肾脏嗜性与急性肾损伤的关联——作者回复
Lancet. 2020 Dec 12;396(10266):1881-1882. doi: 10.1016/S0140-6736(20)32586-1.
6
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.社论：在 COVID-19 大流行背景下，IBD 的患病率及其并发症不断增加。作者回复。
Aliment Pharmacol Ther. 2020 Jun;51(12):1442-1443. doi: 10.1111/apt.15769. Epub 2020 May 14.
7
In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?'.回复《严重急性呼吸综合征冠状病毒2型血清学对新冠肺炎血液透析患者是否有意义？》
Am J Kidney Dis. 2020 Oct;76(4):598-599. doi: 10.1053/j.ajkd.2020.06.005. Epub 2020 Jun 27.
8
CT screening for early diagnosis of SARS-CoV-2 infection - Authors' reply.CT筛查用于SARS-CoV-2感染的早期诊断——作者回复
Lancet Infect Dis. 2020 Sep;20(9):1011. doi: 10.1016/S1473-3099(20)30247-4. Epub 2020 Mar 26.
9
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.用于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的ChAdOx1新型冠状病毒疫苗——作者回复
Lancet. 2020 Nov 7;396(10261):1486-1487. doi: 10.1016/S0140-6736(20)32267-4.
10
Authors' Reply to: COVID-19 as a "Force Majeure" for Non-COVID-19 Clinical and Translational Research. Comment on "Analysis of Scientific Publications During the Early Phase of the COVID-19 Pandemic: Topic Modeling Study".作者对《将2019冠状病毒病视为非2019冠状病毒病临床及转化研究的“不可抗力”》的回复。对《2019冠状病毒病大流行早期科学出版物分析：主题建模研究》的评论
J Med Internet Res. 2021 May 20;23(5):e29156. doi: 10.2196/29156.
本文引用的文献
1
Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.采用血清学筛查检测血液透析患者中新冠病毒感染的患病率
J Am Soc Nephrol. 2020 Dec;31(12):2966-2967. doi: 10.1681/ASN.2020081193. Epub 2020 Sep 29.
2
High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.使用血清学筛查检测到血液透析患者中无症状 COVID-19 感染的高发生率。
J Am Soc Nephrol. 2020 Sep;31(9):1969-1975. doi: 10.1681/ASN.2020060827. Epub 2020 Jul 30.
3
Epidemiology of COVID-19 in an Urban Dialysis Center.城市透析中心的 COVID-19 流行病学。
J Am Soc Nephrol. 2020 Aug;31(8):1815-1823. doi: 10.1681/ASN.2020040534. Epub 2020 Jun 19.
4
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.体液免疫反应在感染 SARS-CoV-2 后的动态变化和再次感染的可能性。
J Gen Virol. 2020 Aug;101(8):791-797. doi: 10.1099/jgv.0.001439.
5
SARS-CoV-2 shedding and infectivity.严重急性呼吸综合征冠状病毒2型的病毒脱落与传染性。
Lancet. 2020 Apr 25;395(10233):1339-1340. doi: 10.1016/S0140-6736(20)30868-0. Epub 2020 Apr 15.
Zotero 插件